These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 31544248)

  • 1. β-glucan as a new tool in vaccine development.
    Vetvicka V; Vannucci L; Sima P
    Scand J Immunol; 2020 Feb; 91(2):e12833. PubMed ID: 31544248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic effect of dual targeting vaccine adjuvant with aminated β-glucan and CpG-oligodeoxynucleotides for both humoral and cellular immune responses.
    Jin JW; Tang SQ; Rong MZ; Zhang MQ
    Acta Biomater; 2018 Sep; 78():211-223. PubMed ID: 30098441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Designing an immunocyte-targeting delivery system by use of beta-glucan.
    Miyamoto N; Mochizuki S; Sakurai K
    Vaccine; 2018 Jan; 36(1):186-189. PubMed ID: 29174675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel vaccine platform using glucan particles for induction of protective responses against Francisella tularensis and other pathogens.
    Abraham A; Ostroff G; Levitz SM; Oyston PCF
    Clin Exp Immunol; 2019 Nov; 198(2):143-152. PubMed ID: 31400225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta-Glucan Particles as Vaccine Adjuvant Carriers.
    Mirza Z; Soto ER; Dikengil F; Levitz SM; Ostroff GR
    Methods Mol Biol; 2017; 1625():143-157. PubMed ID: 28584989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent advances in oral vaccine development: yeast-derived β-glucan particles.
    De Smet R; Allais L; Cuvelier CA
    Hum Vaccin Immunother; 2014; 10(5):1309-18. PubMed ID: 24553259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. β-Glucan microparticles are good candidates for mucosal antigen delivery in oral vaccination.
    De Smet R; Demoor T; Verschuere S; Dullaers M; Ostroff GR; Leclercq G; Allais L; Pilette C; Dierendonck M; De Geest BG; Cuvelier CA
    J Control Release; 2013 Dec; 172(3):671-8. PubMed ID: 24041710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chitosan, alginate, hyaluronic acid, gums, and β-glucan as potent adjuvants and vaccine delivery systems for viral threats including SARS-CoV-2: A review.
    Mallakpour S; Azadi E; Hussain CM
    Int J Biol Macromol; 2021 Jul; 182():1931-1940. PubMed ID: 34048834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chitosan:β-glucan particles as a new adjuvant for the hepatitis B antigen.
    Soares E; Jesus S; Borges O
    Eur J Pharm Biopharm; 2018 Oct; 131():33-43. PubMed ID: 30048745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunization of guinea pigs against Entamoeba histolytica using glucan as an adjuvant.
    Sharma A; Haq AU; Siddiqui MU; Ahmad S
    Int J Immunopharmacol; 1984; 6(5):483-91. PubMed ID: 6094370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 6-O-Branched Oligo-β-glucan-Based Antifungal Glycoconjugate Vaccines.
    Liao G; Zhou Z; Liao J; Zu L; Wu Q; Guo Z
    ACS Infect Dis; 2016 Feb; 2(2):123-31. PubMed ID: 27624963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody response in silver catfish (Rhamdia quelen) immunized with a model antigen associated with different adjuvants.
    Pavan TR; Di Domenico J; Kirsten KS; Nied CO; Frandoloso R; Kreutz LC
    Braz J Med Biol Res; 2016 Jul; 49(8):. PubMed ID: 27464022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant Activity Enhanced by Cross-Linked CpG-Oligonucleotides in β-Glucan Nanogel and Its Antitumor Effect.
    Miyamoto N; Mochizuki S; Fujii S; Yoshida K; Sakurai K
    Bioconjug Chem; 2017 Feb; 28(2):565-573. PubMed ID: 27951636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-glucan-CRM197 conjugates as candidates antifungal vaccines.
    Bromuro C; Romano M; Chiani P; Berti F; Tontini M; Proietti D; Mori E; Torosantucci A; Costantino P; Rappuoli R; Cassone A
    Vaccine; 2010 Mar; 28(14):2615-23. PubMed ID: 20096763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conjugation of β-glucan markedly increase the immunogencity of meningococcal group Y polysaccharide conjugate vaccine.
    Qiao W; Ji S; Zhao Y; Hu T
    Vaccine; 2015 Apr; 33(17):2066-72. PubMed ID: 25728319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carbonate Apatite Nanoparticles Act as Potent Vaccine Adjuvant Delivery Vehicles by Enhancing Cytokine Production Induced by Encapsulated Cytosine-Phosphate-Guanine Oligodeoxynucleotides.
    Takahashi H; Misato K; Aoshi T; Yamamoto Y; Kubota Y; Wu X; Kuroda E; Ishii KJ; Yamamoto H; Yoshioka Y
    Front Immunol; 2018; 9():783. PubMed ID: 29720976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucan Particles: Choosing the Appropriate Size to Use as a Vaccine Adjuvant.
    Colaço M; Panão Costa J; Borges O
    Methods Mol Biol; 2022; 2412():269-280. PubMed ID: 34918250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dietary whole glucan particles do not affect antibody or cell-mediated immune responses to influenza virus vaccination in mice.
    Pence BD; Hester SN; Donovan SM; Woods JA
    Immunol Invest; 2012; 41(3):275-89. PubMed ID: 22149961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Duality of β-glucan microparticles: antigen carrier and immunostimulants.
    Baert K; De Geest BG; De Greve H; Cox E; Devriendt B
    Int J Nanomedicine; 2016; 11():2463-9. PubMed ID: 27330289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microbial exopolysaccharides-β-glucans-as promising postbiotic candidates in vaccine adjuvants.
    Abbasi A; Rahbar Saadat T; Rahbar Saadat Y
    Int J Biol Macromol; 2022 Dec; 223(Pt A):346-361. PubMed ID: 36347372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.